GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioHarvest Sciences Inc (XCNQ:BHSC) » Definitions » EV-to-Revenue

BioHarvest Sciences (XCNQ:BHSC) EV-to-Revenue : 12.46 (As of May. 25, 2024)


View and export this data going back to 2015. Start your Free Trial

What is BioHarvest Sciences EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, BioHarvest Sciences's enterprise value is C$167.05 Mil. BioHarvest Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was C$13.41 Mil. Therefore, BioHarvest Sciences's EV-to-Revenue for today is 12.46.

The historical rank and industry rank for BioHarvest Sciences's EV-to-Revenue or its related term are showing as below:

XCNQ:BHSC' s EV-to-Revenue Range Over the Past 10 Years
Min: 6.98   Med: 32.82   Max: 647.21
Current: 12.46

During the past 10 years, the highest EV-to-Revenue of BioHarvest Sciences was 647.21. The lowest was 6.98. And the median was 32.82.

XCNQ:BHSC's EV-to-Revenue is ranked worse than
94.47% of 1879 companies
in the Consumer Packaged Goods industry
Industry Median: 1.18 vs XCNQ:BHSC: 12.46

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-25), BioHarvest Sciences's stock price is C$0.25. BioHarvest Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.03. Therefore, BioHarvest Sciences's PS Ratio for today is 9.26.


BioHarvest Sciences EV-to-Revenue Historical Data

The historical data trend for BioHarvest Sciences's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioHarvest Sciences EV-to-Revenue Chart

BioHarvest Sciences Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 183.78 76.85 19.49 7.39

BioHarvest Sciences Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.69 19.49 10.77 9.33 7.39

Competitive Comparison of BioHarvest Sciences's EV-to-Revenue

For the Packaged Foods subindustry, BioHarvest Sciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioHarvest Sciences's EV-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioHarvest Sciences's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where BioHarvest Sciences's EV-to-Revenue falls into.



BioHarvest Sciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

BioHarvest Sciences's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=167.047/13.407
=12.46

BioHarvest Sciences's current Enterprise Value is C$167.05 Mil.
BioHarvest Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$13.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioHarvest Sciences  (XCNQ:BHSC) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

BioHarvest Sciences's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.25/0.027
=9.26

BioHarvest Sciences's share price for today is C$0.25.
BioHarvest Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioHarvest Sciences EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of BioHarvest Sciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


BioHarvest Sciences (XCNQ:BHSC) Business Description

Traded in Other Exchanges
Address
1140-625 Howe Street, Vancouver, BC, CAN, V6C 2T6
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

BioHarvest Sciences (XCNQ:BHSC) Headlines

No Headlines